Prostamax 20 mg
$70.00
Dragon Pharma Prostamax 20 mg – Synthetic Tetrapeptide for Prostate Cell Research
Dragon Pharma Prostamax 20 mg is a synthetic tetrapeptide bioregulator with the amino acid sequence Lys-Glu-Asp-Pro (KEDP). As part of the well-characterized Khavinson peptide family, this compound has been investigated in laboratory settings for its role in cellular signaling, chromatin decondensation, and tissue-specific responses in prostate cell cultures.
Each vial contains 20 mg of lyophilized Prostamax in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Prostamax represents a targeted research tool for investigating prostate cell biology, gene expression regulation, and the molecular mechanisms underlying tissue-specific responses. For related research compounds, explore our peptides category and specifically Epitalon 50 mg for complementary cellular regulation studies.
What Makes Prostamax Valuable in Research?
Prostamax belongs to a class of short-chain peptides known for their tissue-specific bioregulatory properties. The KEDP sequence has been studied for its ability to influence cellular processes relevant to prostate biology, including chromatin remodeling, gene expression modulation, and cell signaling pathways. Its defined sequence and mechanism of action make it a practical tool for investigating the molecular basis of prostate cell function and regulation.
Researchers value Prostamax for its targeted approach to studying prostate cell biology. Its ability to modulate chromatin structure and cellular signaling provides insights into the mechanisms that govern tissue-specific responses and gene regulation. For investigators exploring other areas of cellular regulation, Livagen 20 mg offers complementary research avenues in chromatin remodeling and gene expression studies.
Current scientific literature on Khavinson peptides, including Prostamax, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.
Key Research Applications for Dragon Pharma Prostamax
- ✔ Investigation of prostate cell signaling pathways
- ✔ Evaluation of chromatin decondensation mechanisms
- ✔ Research on tissue-specific gene expression regulation
- ✔ Studies of peptide bioregulation in prostate models
- ✔ Preclinical models of prostate cell function and response
Prostamax 20 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on cellular signaling, Ovagen 20 mg provides additional research avenues in tissue-specific peptide regulation.